Dr. Paul Kun Row, MD

Dr. Row practices at Eye Care Center of Napa Valley a Medical Corporation in Napa, California.

Dr. Row's NPI, 1548345580, was assigned on October 26, 2006. Dr. Row graduated from Loma Linda University School Of Medicine in 1999. Dr. Row holds California license A74103.

Dr. Row's primary practice is Eye Care Center of Napa Valley a Medical Corporation, at 895 Trancas St, Napa, CA 94558 in Napa County. The practice phone is (707) 252-2020.

Dr. Row's primary practice is Eye Care Center of Napa Valley a Medical Corporation in Napa, California. Dr. Row is also affiliated with Providence Queen of the Valley Medical Center. Dmand AI also links Dr. Row to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Row practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Row's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Row is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Row's licenses on file in 2 states: California and Iowa.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Row treats.

CMS data shows 4,430 Medicare services from Dr. Row across 20 procedure codes in 2024, for 1,240 Medicare patients. Medicare paid $439,125 for them.

CMS counts 1,240 Medicare patients who saw Dr. Row in 2024. The largest group is 75 to 84, with 568 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Row's median patient age at 73, with 57% women.

In 2024, Dr. Row wrote 1,971 Medicare Part D claims for 409 patients. 65% of them were for generic drugs. CMS names the drug for 1,886 of them, across 22 drugs with 11 or more claims each, at $188,018 in total drug cost. In 2023, CMS named 1,703 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Row for performance year 2024, reported as part of a group. Dr. Row accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 358 procedures of cataract surgery by Dr. Row, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Row. Dr. Row's most frequent co-authors are Scott William Beeve, MD and Scott Dragosh Ispirescu, MD.

CMS Open Payments shows 242 general payments to Dr. Row from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Alcon Laboratories Inc paid the most, $2,119.

Dmand AI lists 2 awards for Dr. Row, most recently CMS Stage 1 EHR in 2013.

Dr. Row graduated from Loma Linda University School Of Medicine in 1999. Dr. Row is a member of AAO.

Dr. Row is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.